NewTimeSpace News: Shenzhen HQVT Technology Co., Ltd. (01392.HK) was listed on the Hong Kong Stock Exchange today with a final offer price of HK$7.20 per share. At market close, the stock settled at HK$26.70, representing a rise of HK$19.50 or 270.83% over the offer price. It hit an intraday high of HK$30 and a low of HK$25, with total trading turnover of HK$709 million and latest market capitalization of HK$20.189 billion.
NewTimeSpace News: Hj Science Co., Ltd. (06132.HK) launched grey market trading today. As of press time, its grey market price stood at HK$74.20, down HK$7.60 or 9.29% compared with the IPO offer price.
NewTimeSpace News: Grey market trading of Senior Material (06067.HK) commenced on 22 June. As of press time, the grey market price hit HK$12.16, representing a 35.41% increase compared with the offer price of HK$8.98, with formal listing scheduled for the next day. The total number of offer shares stood at 149.52 million, raising gross proceeds of approximately HK$1.263 billion.
NewTimeSpace News: BASiC Semiconductor Co., Ltd. passed the HKEX listing hearing on 21 June, with Guojin Securities (Hong Kong) and BOC International acting as joint sponsors. Founded in 2016, the firm focuses on R&D, manufacturing and sales of silicon carbide power devices. Per Frost & Sullivan data based on 2024 revenue, it ranks 6th in China’s SiC power module market with a 2.9% share, and 9th in both China’s SiC discrete device market (2.7% share) and power semiconductor gate driver market (1.7% share). The domestic SiC power device market surged from RMB1.1 billion in 2020 to RMB6.9 billion in 2024 at a CAGR of 59.7%, and is projected to hit RMB42.8 billion by 2029. The market remains highly concentrated, with leading international players capturing over 50% share in both SiC module and discrete device markets.
NewTimeSpace News: Tanboer Group Co., Ltd. passed the listing hearing of The Stock Exchange of Hong Kong Limited on 21 June, with China International Capital Corporation (CICC) acting as the sole sponsor. According to China Insights Consultancy (CIC), by retail sales volume in 2025, the Group ranks as China’s 7th largest professional outdoor apparel brand with a market share of 2.2%, and the 4th largest domestic professional outdoor apparel brand capturing a 5.0% market share. Its online channel revenue jumped from RMB349 million in 2023 to RMB1.254 billion in 2025, representing a two-year growth of approximately 260%.
NewTimeSpace News: DataStory Artificial Intelligence Technology Co., Ltd. submitted its listing application to the Hong Kong Stock Exchange on 18 June, with CITIC Construction Investment International acting as the sole sponsor. The company ranks third by revenue in China’s enterprise LLM-powered business growth market for 2025, posting full-year revenue of RMB503.3 million, representing a year-on-year growth of 77.6%. It has served more than 65 Fortune Global 500 corporations as of 31 March 2026.
NewTimeSpace News: Guangzhou Zhiyi Biotechnology Co., Ltd. filed a listing application with the Hong Kong Stock Exchange on 18 June, jointly sponsored by Guotou Securities International and Industrial Securities International. The clinical-stage biotech firm specialises in Live Biotherapeutic Products (LBPs), with core asset SK08 targeting irritable bowel syndrome and ulcerative colitis, and SK10 for chemotherapy-induced diarrhoea. As a pioneer of second-generation LBPs in China, it participated in formulating industry standards for Akkermansia muciniphila. The global LBP market reached USD4.7 billion in 2025 and is projected to hit USD7.5 billion by 2030, per Frost & Sullivan data.
NewTimeSpace News: Shenzhen Transsion Holdings Co., Ltd. (688036.SH) refiled its H-share listing application with the Hong Kong Stock Exchange on 18 June, with CITIC Securities acting as the sole sponsor. Ranked the No.1 mobile phone supplier across global emerging markets by 2024 shipment volume, it takes the top position in Africa and emerging Asia Pacific regions, with sales footprint covering over 100 countries and territories. The Group shipped 169 million mobile handsets in 2025, and Transsion OS recorded over 290 million monthly active users.
NewTimeSpace News: CSPC Innovation Pharmaceutical Co., Ltd. refiled its listing application with the Hong Kong Stock Exchange on 18 June, with CITIC Securities acting as the sole sponsor. The company ranks as the world’s largest manufacturer of chemically synthesized caffeine by revenue and shipment volume from 2020 to 2025, serving major global clients including The Coca-Cola Company, PepsiCo and Red Bull GmbH. Its business portfolio has expanded into health food, functional pharmaceutical APIs and biopharmaceuticals covering antibodies, ADCs and mRNA vaccines; the Group acquired equity interest in Jushi Bio in 2024 to foray into biotech.
NewTimeSpace News: Jiangxi Institute of Biological Products Inc. (06915.HK) commences its public offering on 22 June, with a board lot of 500 shares and an entry fee of roughly HK$6,595.86. The offer price range is HK$9.33 to HK$13.06 per share. The Company plans a global offering of approximately 36.2345 million H-shares and expects to list on 30 June. WSH has been introduced as the sole cornerstone investor with a total subscription consideration of HK$50 million. Based on the median offer price of HK$11.20, it will subscribe for around 4.464 million Offer Shares, accounting for approximately 12.32% of the total Global Offering shares (assuming the Over-allotment Option is not exercised).
NewTimeSpace News: Guangdong True Health Medical Technology Development Co., Ltd. (02697.HK) kicks off its public offering on 22 June, with a board lot size of 20 shares and an entry fee of roughly HK$2,735.30. The offer price range is HK$119.30 to HK$135.40 per share. The Company plans a global offering of approximately 3.5647 million H-shares and expects to list on 30 June. No cornerstone investors have been introduced for this offering.
NewTimeSpace News: Zhejiang Laifual Drive Co., Ltd. (03952.HK) commences its public offering on 22 June, with a board lot of 100 shares and an entry fee of roughly HK$8,636.22. The offer price range stands at HK$77.00 to HK$85.50 per share. The Company plans a global offering of approximately 13.4419 million H-shares and expects to list on 30 June. Ten cornerstone investors including Oaktree, Mingshan Capital, Harvest Global and CDH Global have been introduced, collectively subscribing for 5.3036 million Offer Shares, accounting for around 39.44% of the total Global Offering shares (assuming the Over-allotment Option is not exercised).
NewTimeSpace News: Hangzhou Qiandaohu Xunlong Sci-tech Co., Ltd. (06715.HK) kicks off its public offering on 22 June, with a board lot size of 100 shares and an entry fee of roughly HK$7,626. The Company plans a global offering of approximately 16.3329 million H-shares at an offer price of HK$75.50 per share, with listing scheduled for 30 June. It has secured eight cornerstone investors including BlackRock Funds, Baring, Taikang Life and Greenwoods Asset Management, with aggregate subscription amount equivalent to around US$78.5 million.
NewTimeSpace News: Shares of Shenzhen HQVT Technology Co., Ltd. traded at HK$23.76 in today’s grey market session, representing a rise of HK$16.56 or 230% compared with the offer price of HK$7.2. The Company will be formally listed on the HKEX Main Board on 22 June.
NewTimeSpace News: The listing application submitted by EpimAb Biotherapeutics Inc. to the Hong Kong Stock Exchange on 18 December 2025 has lapsed upon the expiry of the six-month validity period, with CITIC Securities and CMB International Capital serving as the original joint sponsors. Founded in 2015, the Company is a clinical-stage biotech enterprise focusing on the development of bispecific antibodies for various cancers and autoimmune diseases. Its core asset EMB-01 (targeting EGFR/cMET) is mainly indicated for metastatic colorectal cancer, currently under Phase II monotherapy development and Phase Ib combination therapy development.
NewTimeSpace News: The listing application submitted by COREE Company Limited to the Hong Kong Stock Exchange on 18 December 2025 has lapsed upon the expiry of the six-month validity period, with China International Capital Corporation acting as the original sole sponsor. Originated from South Korea, the Company is an integrated healthcare solution provider with core operations in China and expanding global footprint. According to Frost & Sullivan, measured by 2024 revenue, it ranks as China’s largest service provider for paediatric pharmaceutical marketing, promotion and sales, capturing approximately 15.9% of the domestic market share.
